Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide

Mei Chuan Huang, Nigel H. Greig, Weiming Luo, David Tweedie, Janice B. Schwartz, Dan L. Longo, Luigi Ferrucci, William B. Ershler, Edward J. Goetzl

Research output: Contribution to journalArticle

Abstract

Lenalidomide, an analog of thalidomide, modified responses of stimulated T cells from healthy young (ages 21-40. years) and old (

Original languageEnglish (US)
Pages (from-to)201-211
Number of pages11
JournalClinical Immunology
Volume138
Issue number2
DOIs
StatePublished - Feb 2011
Externally publishedYes

Keywords

  • Apoptosis
  • Chemotaxis
  • Cytokines
  • Human
  • Proliferation
  • T lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide'. Together they form a unique fingerprint.

  • Cite this

    Huang, M. C., Greig, N. H., Luo, W., Tweedie, D., Schwartz, J. B., Longo, D. L., Ferrucci, L., Ershler, W. B., & Goetzl, E. J. (2011). Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide. Clinical Immunology, 138(2), 201-211. https://doi.org/10.1016/j.clim.2010.11.002